|
|
Î÷ºçÍø
Î÷ºçÍø2021Ä꣬һ²¿¼²²¡Ìâ²ÄµÄµçÓ°¡¶Á˲»ÆðµÄÀϰ֡·ÈÈÓ³£¬½²ÊöµÄÊÇÒò»¼¶à·¢ÐÔÓ²»¯Ö¢¶øÊÓÁ¦ÕϰµÄÄÐÖ÷½ÇФ¶û¶«ÔÚ¸¸Ç×µÄÒýµ¼Ï·ÜÁ¦Íê³ÉÂíÀËɱÈÈüµÄ¹ÊÊ£¨Í¼1£©¡£Ó°Æ¬²»½ö´«´ïÁËÖ÷È˹«²»Çü·þÃüÔ˵ľ«ÉñÄÚº£¬»¹½«¡°¶à·¢ÐÔÓ²»¯Ö¢¡±ÕâÒ»º±¼ûµÄÉñ¾ÏµÍ³¼²²¡´øÈëÁË´óÖÚÊÓÒ°¡£NMNhttps://www.nmn.cnÈðÎ¬ÍØNMN_NAD+ǰÌå²¹³ä¼Áͨ¹ý¹Û²ìNMNÐÐÒµÖйúÊг¡·¢Õ¹,¶ÔNMN¹¦Ð§Óë×÷ÓýøÐÐÉîÈëÑо¿,×ÔÈðÎ¬ÍØÉÏÊйúÄÚÊг¡ÒÔÀ´,²»¶Ï¸ïÐÂNMNÅä·½¼°NMNÌáÈ¡¼¼Êõ,ƾ½èŵ½±ÌáÃûµÄÉúÎïø¶¨Ïò¼¼Êõ³ÉΪNMNÐÐÒµµì»ùÕß,ΪNMNÐÐÒµ·¢Õ¹Ê÷Á¢Ð·½Ïò£¡ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÍ¼1. µçÓ°¡¶Á˲»ÆðµÄÀϰ֡·Öи¸Ç×ÓÃÇ£ÒýÉþ°ïÖúÊÓÁ¦ÕϰµÄ¶ù×ÓÍê³ÉÂíÀËɱÈÈü Î÷ºçÍø
Î÷ºçÍø¶à·¢ÐÔÓ²»¯Ö¢ÊÇÒ»ÖÖ×î³£¼ûµÄÖÐÊàÉñ¾ÏµÍ³ÍÑËèÇʲ¡£¬³£·¢ÉúÓïÑÔ¡¢ÊÓÁ¦¡¢¾«ÉñÕϰ£¬¼°Ö«ÌåÂé±ÔÖÁ̱»¾µÈÇé¿ö£¬ÒòÆäÖ²ÐÂʸßÇҸ߷¢ÓÚÇà׳Ä꣬Ҳ±»³ÆÖ®Îª¡°²»ËÀ°©Ö¢¡±¡£Ñо¿±íÃ÷[1]£¬·ÊÅÖÊǶ෢ÐÔÓ²»¯Ö¢µÄÒ»¸ö¹Ø¼ü·çÏÕÒòËØ£¬Æä»áµ¼ÖÂÄÔ°×ÖÊÒì³£ºÍÖÐÊàÉñ¾ÏµÍ³ÉÙÍ»½ºÖÊϸ°ûµÄ¶ªÊ§¡£Òò´Ë£¬Óë·ÊÅÖÏà¹ØµÄ¸ßÖ¬Òûʳ»òȱ·¦Ô˶¯¾ù¿ÉÄÜÊÇËðÉËËèÇÊ£¬ÓÕ·¢¶à·¢ÐÔÓ²»¯Ö¢µÄ²»ÀûÒòËØ£¬µ«¾ßÌå×÷ÓûúÖÆÈÔÉдýÑо¿¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÀ´×ÔÃÀ¹ú÷°ÂÕïËù£¨Mayo Clinic£©µÄLangleyµÈÈ˵ÄÑо¿¶Ô¿ÉÄܵĻúÖÆÌá³öÁËÐÂ˼·£¬¼´ÉãÈë¸ßÖ¬Òûʳ»áÒý·¢´úлÎÉÂÒ£¬Éý¸ßÒ»ÖÖÃûΪ¡°CD38¡±µÄµ°°×£¨NAD+ÏûºÄø£©º¬Á¿¶øÏûºÄÑÌõ£°·ÏÙàÑßʶþºËÜÕËᣨNicotinamide adenine dinucleotide£¬NAD+£©£¬µ¼ÖÂÐÇÐνºÖÊϸ°û»î»¯£¬ÉÙÍ»Éñ¾½ºÖÊϸ°û²¡±ä£¬´Ó¶øËðº¦ËèÇÊÔÙÉú£¬µ«NAD+ǰÌåÑÌõ£°·µ¥ºËÜÕËᣨNMN£©¿ÉÓÐÐ§Äæ×ªÉÏÊö²»ÀûÓ°Ï졣Ŀǰ¸ÃÑо¿ÒÑ·¢±íÔÚ¡¶Éñ¾¿ÆÑ§ÔÓÖ¾¡·£¨Journal of Neuroscience£©[2]ÉÏ¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÍ¼2.¡¶Éñ¾¿ÆÑ§ÔÓÖ¾¡·¿¯µÇµÄÎÄÕ³ƣ¬ÐÇÐνºÖÊϸ°ûÖÐNAD+µÄÏûºÄøÔÚËèÇÊËðÉ˺ÍÔÙÉúÖÐÆð¹Ø¼ü×÷Óà Î÷ºçÍø
Î÷ºçÍø¸ßÖ¬Òûʳ¡¢NAD+Óë¶à·¢ÐÔÓ²»¯Ö¢µÄÏà¹ØÐÔ Î÷ºçÍø
Î÷ºçÍø¸ßÖ¬Òûʳ»áÆÆ»µÒ»ÖÖ±»³ÆÎª¡°ÉÙÍ»½ºÖÊ¡±µÄËèÇÊϸ°ûºÍÁíÒ»ÖÖ±»³ÆÎª¡°ÐÇÐνºÖÊ¡±µÄÉñ¾Ï¸°û£¬ÕâÁ½ÖÖϸ°û¾ù·Ö²¼ÓÚÖÐÊàÉñ¾ÏµÍ³¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÐÇÐνºÖÊϸ°ûÊÇÌå»ý×î´ó¡¢ÊýÁ¿×î¶à¡¢¹¦ÄÜ×ÔÓµÄÉñ¾½ºÖÊϸ°û¡£Ö÷Òª·¢»ÓÖ§³ÖºÍ·Ö¸ôÉñ¾Ï¸°ûµÄ×÷Ó㬲¢²ÎÓëѪÄÔÆÁÕÏ£¬¶ÔµÝÖÊ´úл¡¢ÐźŴ«µÝ¾ßÓÐÖØÒª×÷Óã»ÉÙÍ»½ºÖÊϸ°ûÔÚÄÔ°×ÖÊÖУ¬²¢ÅÅ´æÔÚÓÚÓÐËèÉñ¾ÏËά֮¼ä£¬¹¹³ÉËèÇÊ£¬Ö÷ÒªÐÖúÐźŴ«µÝºÍά»¤Éñ¾Ôª¹¦ÄÜ£¬ÕâÁ½ÖÖÉñ¾Ï¸°û¹¦ÄÜÒì³£¿ÉÄܻᵼÖÂÖÐÊàÉñ¾ÏµÍ³ÍÑËèÇʲ¡±ä¡¢Éñ¾ÔªËðÉË»ò¾«ÉñÀàµÈ¼²²¡£¨Í¼3£©¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÍ¼3. ÐÇÐνºÖÊϸ°ûÓëÉÙÍ»½ºÖÊϸ°û½á¹¹Í¼ Î÷ºçÍø
Î÷ºçÍøNAD+ÊÇά³Öϸ°ûÄÜÁ¿µÄ¹Ø¼üÎïÖÊ£¬²ÎÓë¶àÖÖ´úл¹ý³Ì£¬°üÀ¨Ö¬·¾´úл¡£¶øÒÑÓÐÑо¿±íÃ÷[3]£¬CD38ÊÇÉñ¾Ï¸°ûÖÐNAD+µÄÖ÷ÒªÏûºÄø£¬ÆäˮƽÔÚ¶à·¢ÐÔÓ²»¯Ö¢ºÍ¸ßÖ¬ÒûʳÉãÈëºó¾ùÏÔÖøÉý¸ß¡£Òò´Ë£¬LangleyµÈÈËÔÚ´Ë»ù´¡ÉϼÌÐøÉîÈë̽¾¿ÁËNAD+¡¢CD38¡¢¸ßÖ¬ÒûʳÓë¶à·¢ÐÔÓ²»¯Ö¢µÈÍÑËèÇÊÀ༲²¡Ö®¼äµÄ¹ØÏµ¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍø¸ßÖ¬Òûʳ¿ÉÔö¼ÓÉñ¾Ï¸°ûÖÐCD38º¬Á¿£¬½µµÍNAD+ˮƽ Î÷ºçÍø
Î÷ºçÍø¿¼Âǵ½ÐÇÐνºÖÊϸ°ûÔÚ¸÷ÖÖÉñ¾ÏµÍ³¼²²¡²¡ÀíÖеÄ×÷Óã¬LangleyµÈÈËÊ×ÏÈѡȡ¸ÃÀàϸ°û½øÐÐÁ˸ßÖ¬ÒûʳµÄ´úлÑо¿¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÑо¿·¢ÏÖ£¬Ïà±ÈÕý³£Î¹Ñø£¨Ö¬·¾º¬Á¿Õ¼×ÜÒûʳÁ¿µÄ10%£¬Á¬ÐøÎ¹Ñø12ÖÜ£©µÄСÊ󣬸ßÖ¬Î¹Ñø£¨Ö¬·¾º¬Á¿60%£¬Á¬ÐøÎ¹Ñø12ÖÜ£©Ð¡ÊóµÄÈ«Ëè×éÖ¯ÖÐNAD+ˮƽÏÔÖø½µµÍ£¨Í¼4A£©£¬ÐÇÐνºÖÊϸ°ûÖеÄCD38º¬Á¿ÏÔÖøÉý¸ß£¨Í¼4B£©¡£¶øÌåÍâÅàÑø±íÏÖÁËÓ붯ÎïˮƽÏàÒ»ÖµĽá¹û£¨Í¼4C-F£©¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÕâЩÊý¾Ý±íÃ÷£¬¸ßÖ¬Òûʳ¿ÉÓÕµ¼¶¯ÎïÉñ¾ÏµÍ³ÖÐÐÇÐνºÖÊϸ°û»î»¯£¬Ôö¼ÓCD38º¬Á¿£¬¼Ì¶ø¼õÉÙNAD+µÄˮƽ£¬Ö¤ÊµÁËÏÈǰµÄÑо¿½á¹û£¬¼´CD38ÔÚ¸ßÖ¬ÒûʳÉãÈëºóÏÔÖøÉý¸ß¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÍ¼4. ¸ßÖ¬Òûʳ¿É»î»¯ÐÇÐνºÖÊϸ°û£¬Ôö¼ÓCD38º¬Á¿£¬¼õÉÙNAD+ˮƽ¡£ Î÷ºçÍø
Î÷ºçÍøÍ¼AΪȫËè×éÖ¯ÖÐNAD+º¬Á¿£»Í¼BΪÐÇÐνºÖÊϸ°ûÖÐCD38º¬Á¿£»Í¼CΪCD38ºÍÐÇÐνºÖÊϸ°ûµÄÃâÒßÓ«¹âͼ£»Í¼D-FΪÌåÍâ¸ßÖ¬ÅàÑøÌõ¼þÏ£¬ÐÇÐνºÖÊϸ°û¡¢CD38ºÍNAD+µÄ±ä»¯¡£ÆäÖÐGFAPÊÇÐÇÐνºÖÊϸ°û»î»¯µÄ±êÖ¾Îï¡£ Î÷ºçÍø
Î÷ºçÍøÒÖÖÆCD38»îÐÔ£¬¿ÉµÖ¿¹¸ßÖ¬ÒûʳÒýÆðµÄÉñ¾Ï¸°û¼õÉÙ Î÷ºçÍø
Î÷ºçÍøÓÉÓÚÉÙÍ»½ºÖÊϸ°ûÊÇËèÇʵÄÖØÒª×é³É²¿·Ö£¬¶øÖ®Ç°µÄÑо¿[4,5]±íÃ÷ÇóýCD38»ùÒò¿ÉÓÐЧµÖ¿¹Ð¡ÊóµÄÍÑËèÇÊ£¬Òò´ËLangleyµÈÈ˼ÌÐø¶ÔÆäÓë¸ßÖ¬ÒûʳµÄ¹ØÏµ½øÐÐÁËÑо¿£¬²¢×ÅÖØÌ½¾¿ÁËCD38µÄ×÷ÓᣠÎ÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÑо¿½«¶¯Îï·ÖÕý³£Ð¡ÊóºÍCD38ÇóýСÊó¡£ÔÚÿÖÖСÊó50ÖÜʱ·Ö±ð½øÐÐÕý³££¨10.4%Ö¬·¾£©ºÍ¸ßÖ¬£¨42%Ö¬·¾£©Î¹Ñø£¬30Öܺó·ÖÎöËÄ×éСÊóµÄ¼¹ËèÑù±¾£¨Í¼5£©¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÍ¼5. ¶¯ÎïʵÑéÁ÷³Ìͼ Î÷ºçÍø
Î÷ºçÍø½á¹ûÏÔʾ£¬ÓëÐÇÐνºÖÊϸ°û½á¹ûÏàËÆ£¬Õý³£×éµÄ¸ßÖ¬Î¹ÑøÐ¡Êó¼¹ËèÖÐCD38ˮƽÉý¸ß¶øNAD+ˮƽ½µµÍ£¬È»¶øÖµµÃ×¢ÒâµÄÊÇ£¬ÉÙÍ»½ºÖÊϸ°ûµÄÊýÁ¿·¢ÉúÏÔÖøÏ½µ¡£µ«µ±ÇóýCD38ºó£¬·¢ÏÖСÊó¿ÉÃâÊܸßÖ¬ÓÕµ¼µÄNAD+½µµÍºÍÉÙÍ»½ºÖÊϸ°ûµÄ¶ªÊ§£¨Í¼6£©¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÍ¼6. ÒÖÖÆCD38»îÐÔ£¬¿ÉµÖ¿¹¸ßÖ¬ÒûʳÒýÆðµÄÉÙÍ»½ºÖÊϸ°ûËðʧ¡£ Î÷ºçÍø
Î÷ºçÍøÍ¼AºÍBΪ¸ßÖ¬Òûʳ¶ÔNAD+ºÍCD38»îÐÔµÄÓ°Ï죻ͼCΪ¼¹ËèÈ¡ÉÙÍ»½ºÖÊϸ°ûµÄλÖÃʾÒâͼ£¬·ÖΪ¼¹Ëè±³ÖùºÍÄÔ°×ÖÊÁ½´¦£»Í¼DΪÕý³£×éºÍCD38Çóý×éСÊóÔÚÕý³£Î¹ÑøºÍ¸ßÖ¬Î¹ÑøÏÂÉÙÍ»½ºÖÊϸ°û±êÖ¾ÎïµÄÃâÒßȾɫͼ£»Í¼EΪ¸ù¾ÝÃâÒßȾɫ½øÐÐÉÙÍ»½ºÖÊϸ°ûµÄ¶¨Á¿·ÖÎö¡£ Î÷ºçÍø
Î÷ºçÍøNMN¿É»Ö¸´¸ßÖ¬Òûʳ¶ÔÉñ¾Ï¸°ûµÄËðÉË£¬ÐÖúËèÇÊÔÙÉú Î÷ºçÍø
Î÷ºçÍø¶¯ÎïˮƽÉпÉʵÏÖCD38»ùÒò»ùÒòÇóý£¬µ«¶ÔÓÚÈËÌåÉÐÓÐÄѶȡ£Òò´Ë£¬LangleyµÈÈËÊÔͼ´ÓÁíÒ»ÖֽǶÈÌá¸ßNAD+ˮƽÀ´¸ÄÉÆ¸ßÖ¬¶ÔÉÙÍ»½ºÖÊϸ°ûµÄËðÉË£¬¼´Ê¹ÓÃNAD+ǰÌå¦Â-ÑÌõ£°·µ¥ºËÜÕËá(Nicotinamide mononucleotide£¬NMN)¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍø½á¹ûÏÔʾ£¬Ïà±ÈÕý³£×飬¸ßÖ¬ÏÔÖø½µµÍÉÙÍ»½ºÖÊϸ°ûµÄÊýÁ¿ºÍËèÇʵ°°×µÄˮƽ£¬µ«ÁªºÏNMN£¨100 ¦ÌM£©¹²ÅàÑøºó£¬¶þÕ߿ɻָ´ÖÁÕý³£Ë®Æ½£¬¶ø¸üΪÓÐȤµÄÊÇ£¬NMNµÄ×÷ÓÃÊÇÒÀÀµÓÚÒ»ÖÖ±»³ÆÎª¡°³¤ÊÙÒò×Ó¡±µÄSIRT1µ°°×»îÐÔ£¬µ±Ê¹ÓÃSIRT1ÒÖÖÆ¼ÁEX527£¨5 ¦ÌM£©Ê±£¬NMN±ãʧȥ»Ö¸´×÷Óã¨Í¼7£©¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøÍ¼7. NMN ¿É»Ö¸´¸ßÖ¬Òûʳ¶ÔÉÙÍ»½ºÖÊϸ°û·Ö»¯µÄËðÉË¡£ Î÷ºçÍø
Î÷ºçÍøÍ¼AΪÉÙÍ»½ºÖÊϸ°ûµÄÃâÒßÓ«¹âͼ£»Í¼B-CΪËèÇʵ°°×º¬Á¿±ä»¯Í¼£¬´ú±íÉÙÍ»½ºÖÊϸ°ûµÄ·Ö»¯ÄÜÁ¦£»Í¼DΪÉÙÍ»½ºÖÊϸ°ûº¬Á¿Í¼¡£ÆäÖÐConΪÕý³£ÅàÑø×飬PAΪ¸ßÖ¬ÅàÑø×飬PA+NMNΪ¸ßÖ¬ºÍNMN¹²ÅàÑø£¬PA+NMN+EX527Ϊ¸ßÖ¬¡¢NMNºÍEX527¹²ÅàÑø£»PLP£ºËèÁ×Ö¬ËèÇʵ°°×¡¢MBP£ºËèÁ×Ö¬¼îÐÔµ°°×£¬¾ùΪËèÇʵÄÖ÷Òª³É·Ö¡£ Î÷ºçÍø
Î÷ºçÍø¾²Ì¬µÄÐÇÐνºÖÊϸ°ûÓÐÖúÓÚΪÉÙÍ»½ºÖÊϸ°û·Ö»¯ºÍËèÇÊÔÙÉúÌṩ֧³ÖÐÔ»·¾³¡£È»¶ø¸ßÖ¬Òûʳ»áʹ¾²Ì¬ÐÇÐνºÖÊϸ°û»î»¯£¬´Ó¶øÔö¼ÓCD38º¬Á¿£¬ÏûºÄNAD+ˮƽ¡£¶øNAD+µÄϽµÓÖ»áËðÉËÉÙÍ»½ºÖÊϸ°ûµÄ·Ö»¯ºÍ´æ»î¡£Òò´Ë£¬NAD+»òÐíÊÇÓ°ÏìÍÑËèÇÊÀ༲²¡·¢Éú·¢Õ¹µÄÖØÒªÒòËØÖ®Ò»£¬¶ø²¹³äNMN»òÊÇά³ÖÉñ¾Ï¸°ûNAD+ˮƽ¡¢½µµÍ¸ßÖ¬¶ÔÉñ¾Ï¸°ûË𺦡¢Ìá¸ßËèÇÊÐÞ¸´ÄÜÁ¦µÄDZÔÚ·½Ê½Ö®Ò»¡£ Î÷ºçÍø
Î÷ºçÍø Î÷ºçÍø
Î÷ºçÍøLangleyµÈÈ˱íʾ£¬¸ÃÑо¿ÎªÎ´À´²ûÃ÷ÒûʳÓëÉñ¾Ï¸°û·¢Óý¡¢Ë¥ÀÏÌṩÁËÒ»¶¨»ù´¡£¬Í¬Ê±Ò²Ìáʾ×Å£¬Î´À´NAD+ºÍCD38°Ðµã»òÐíÊǸÄÉÆ¶à·¢ÐÔÓ²»¯Ö¢µÈÍÑËèÇÊÀ༲²¡µÄÒ»Ö»¡°Ç±Á¦¹É¡±¡£ |
|